← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2010Last known activity
Nov 30, 2015
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT02629952Lead sponsorN/ANov 30, 2015
- NCT02629952Overall official - principal investigatorN/ANov 30, 2015
- NCT02629952Reponsible party - principal investigatorN/ANov 30, 2015
- NCT01549938Overall official - principal investigatorPhase 2May 1, 2012
- NCT01549938Lead sponsorPhase 2May 1, 2012
- NCT01549938Reponsible party - principal investigatorPhase 2May 1, 2012
- NCT01176344Overall official - principal investigatorPhase 3Aug 1, 2010
- NCT01176344Lead sponsorPhase 3Aug 1, 2010
- NCT01176344Reponsible party - principal investigatorPhase 3Aug 1, 2010
Details
- Last known activity
- Nov 30, 2015